Table 2.
IL-4 and IFN-γ levels in BALF and lung tissues (pg/mL)
| Treatment Group | BALF | Lung tissues | ||
|---|---|---|---|---|
|
| ||||
| IL-4 | IFN-γ | IL-4 | IFN-γ | |
| Control | 48.19±5.33 | 273.89±44.98 | 429.53±34.49 | 915.97±144.05 |
| Untreated asthma | 35.20±5.55* | 350.59±72.80* | 296.63±45.51* | 1322.18±226.75* |
| Pravastatin | 39.18±4.19*,# | 303.99±51.34# | 358.43±68.78*,# | 1243.66±101.58*,# |
| Boletus edulis polysaccharide | 40.88±6.48*,# | 292.97±49.12# | 349.00±41.49*,# | 1123.72±365.82# |
| Dexamethasone | 44.21±8.55# | 288.61±25.81# | 342.58±47.06*,# | 1100.22±139.77# |
| F | 6.355 | 3.275 | 9.604 | 5.086 |
| P | 0.001 | 0.019 | 0.001 | 0.002 |
*
P<0.01, compared with normal group;
#
P<0.05, compared with model group.